This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Smart Approaches to Marijuana | |
|---|---|
| Name | Smart Approaches to Marijuana |
| Type | Advocacy organization |
| Founded | 2013 |
| Founder | Not applicable |
| Headquarters | Not applicable |
| Region served | Not applicable |
Smart Approaches to Marijuana is an advocacy-oriented coalition focused on shaping public policy and public health responses to cannabis legalization debates. The organization engages with policymakers, researchers, advocacy groups, and community leaders to influence legislation, public messaging, and harm-reduction strategies in jurisdictions across the United States and internationally.
Smart Approaches to Marijuana positions itself within debates that include figures and entities such as Jeff Sessions, Mitch McConnell, Nancy Pelosi, Chuck Schumer, Alexandria Ocasio-Cortez, Ron Wyden, Cory Booker, Dianne Feinstein, Kamala Harris, and Joe Biden on the political side, while engaging with scholars associated with Stanford University, Harvard University, Yale University, Columbia University, Johns Hopkins University, University of California, Los Angeles, University of California, San Francisco, University of Pennsylvania, University of Michigan, and University of Toronto on research questions. The coalition interacts with organizations such as National Institute on Drug Abuse, Centers for Disease Control and Prevention, World Health Organization, American Medical Association, American Psychiatric Association, American Academy of Pediatrics, American Public Health Association, Substance Abuse and Mental Health Services Administration, and National Academy of Sciences. It also situates itself amid policy debates involving state actors like California, Colorado, Oregon, Washington (state), Massachusetts, Arizona, Nevada, Michigan, Illinois, New York (state), Vermont, Alaska, Maine, Montana, New Jersey, and Virginia.
The group's legislative outreach has intersected with campaigns, ballot measures, and legislative efforts linked to entities such as NORML, Marijuana Policy Project, Drug Policy Alliance, AARP, Giffords, Moms Demand Action, The Heritage Foundation, Brookings Institution, Cato Institute, American Legislative Exchange Council, National Conference of State Legislatures, Bipartisan Policy Center, The Aspen Institute, Manhattan Institute, Urban Institute, Pew Charitable Trusts, and Rockefeller Foundation. Strategic alliances and oppositions have involved policymakers from Newt Gingrich, John Boehner, Al Franken, Bernie Sanders, Ted Cruz, Lindsey Graham, Marco Rubio, Bill Clinton, Hillary Clinton, Barack Obama, Donald Trump, and Ronald Reagan-era policy legacies. The advocacy tactics echo practices seen in campaigns around Proposition 64 (2016), Amendment 64 (2012), Initiative 71 (2014), Measure 91 (2014), and Question 2 (2012), while referencing legal frameworks like the Controlled Substances Act, Marihuana Tax Act of 1937, and discussions in the United States Congress.
Public health positioning draws on evidence discussed by researchers affiliated with Mount Sinai Health System, Mayo Clinic, Cleveland Clinic, Kaiser Permanente, Dana–Farber Cancer Institute, Fred Hutchinson Cancer Research Center, Scripps Research, Weill Cornell Medicine, Massachusetts General Hospital, and UCSF Benioff Children’s Hospitals. The organization references surveillance and data from Behavioral Risk Factor Surveillance System, National Survey on Drug Use and Health, Youth Risk Behavior Surveillance System, Monitoring the Future, and reports produced by European Monitoring Centre for Drugs and Drug Addiction. Harm-reduction conversations involve stakeholders such as Harm Reduction Coalition, Drug Policy Alliance, Treatment Advocacy Center, Facing Addiction, Partnership to End Addiction, Shatterproof, Hazelden Betty Ford Foundation, Perkins Coie LLP (for legal counsel examples), and public-safety partners like National Highway Traffic Safety Administration, MADD (Mothers Against Drunk Driving), American Automobile Association, and local law enforcement agencies in cities such as Seattle, Denver, Portland (Oregon), San Francisco, Los Angeles, Chicago, Miami, Houston, Philadelphia, and Phoenix.
Research and clinical claims engage with work from institutions and investigators at University of California, San Diego, Massachusetts Institute of Technology, Salk Institute, Scripps Research Institute, Imperial College London, Karolinska Institutet, University of Oxford, University of Cambridge, McGill University, University of Sydney, Monash University, and Hebrew University of Jerusalem. Clinical contexts reference conditions and studies associated with Multiple Sclerosis, Epilepsy, Chemotherapy, HIV/AIDS, Post-traumatic stress disorder, Chronic pain, Parkinson's disease, and Alzheimer's disease research programs at centers like National Institutes of Health, Food and Drug Administration, European Medicines Agency, Medical Research Council (United Kingdom), and specialty groups such as American Academy of Neurology and International Association for the Study of Pain. The organization critiques and cites pharmaceutical and biotech actors including GW Pharmaceuticals, Tilray Brands, Canopy Growth Corporation, Cronos Group, Aurora Cannabis, Aphria, Insys Therapeutics, and major funders like Bill & Melinda Gates Foundation in debates over medicalization, clinical trials, and FDA approval pathways.
Prevention programs and educational outreach connect to models and organizations such as D.A.R.E., Boys & Girls Clubs of America, Big Brothers Big Sisters of America, YMCA, Girl Scouts of the USA, Teach for America, Johns Hopkins Bloomberg School of Public Health, George Washington University Milken Institute School of Public Health, Yale School of Medicine, Columbia Mailman School of Public Health, Rutgers University, University of Florida, Texas A&M University, Pennsylvania State University, and community partners like United Way. Youth intervention strategies reference empirical indicators reported by CDC Foundation, Robert Wood Johnson Foundation, Annie E. Casey Foundation, Kaiser Family Foundation, and programs overseen by state departments in New York City, Los Angeles County, Cook County, Miami-Dade County, Maricopa County, Harris County, and King County.
Legal analyses invoke case law and statutory developments involving decision-makers and courts such as the United States Supreme Court, Ninth Circuit Court of Appeals, Tenth Circuit Court of Appeals, Colorado Supreme Court, California Supreme Court, New York Court of Appeals, as well as legislative instruments like State Constitutions, state ballot processes exemplified by California Proposition 64, Colorado Amendment 64, Washington Initiative 502, and national statutes such as the Controlled Substances Act. Regulatory debates involve agencies and institutions including the Department of Justice, Drug Enforcement Administration, Internal Revenue Service, Treasury Department, Food and Drug Administration, Federal Trade Commission, National Conference of State Legislatures, and international agreements like the Single Convention on Narcotic Drugs and engagements with bodies such as the United Nations Office on Drugs and Crime.
Economic and social impact assessments reference labor, taxation, and equity concerns discussed by organizations and analysts at Bureau of Labor Statistics, U.S. Census Bureau, Office of Management and Budget, Congressional Budget Office, Federal Reserve System, World Bank, International Monetary Fund, Organisation for Economic Co-operation and Development, McKinsey & Company, Deloitte, PricewaterhouseCoopers, Ernst & Young, KPMG, CBRE, JLL (company), and social equity initiatives in cities such as Oakland, Seattle, Portland (Oregon), Denver, Boston, Newark, Detroit, Baltimore, St. Louis, and Cleveland. Debates over criminal justice reform, expungement, and sentencing reference organizations and actors like American Civil Liberties Union, Sentencing Project, Vera Institute of Justice, Equal Justice Initiative, National Association for the Advancement of Colored People, NAACP Legal Defense and Educational Fund, and policymakers involved in clemency and reform measures under administrations such as Barack Obama and Donald Trump.
Category:Advocacy organizations